These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6761860)

  • 21. Sustained antihypertensive effect of captopril combined with diuretics and beta-adrenergic blocking drugs in patients with resistant hypertension.
    Forslund T; Fyhrquist F; Hortling L
    Acta Med Scand; 1983; 213(4):299-303. PubMed ID: 6137132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Captopril in renal artery stenoses and renal insufficiency].
    Kirchertz EJ; Scheler F
    Internist (Berl); 1982 Apr; 23(4):237-40. PubMed ID: 7045027
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril.
    Hollenberg NK
    Am J Med; 1984 May; 76(5B):22-8. PubMed ID: 6328983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience with captopril in the treatment of severe drug-resistant hypertension.
    Raine AE; Ledingham JG
    Am J Cardiol; 1982 Apr; 49(6):1475-9. PubMed ID: 7041586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteinuria during long-term captopril therapy.
    Case DB; Atlas SA; Mouradian JA; Fishman RA; Sherman RL; Laragh JH
    JAMA; 1980 Jul; 244(4):346-9. PubMed ID: 6993700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study of an angiotensin-II analog and a converting enzyme inhibitor.
    Fagard RH; Amery AK; Lijnen PJ; Reybrouck TM
    Kidney Int; 1980 May; 17(5):647-53. PubMed ID: 6249956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term experience with captopril in severe hypertension.
    Havelka J; Boerlin HJ; Studer A; Greminger P; Tenschert W; Luescher T; Siegenthaler W; Vetter W; Walger P; Vetter H
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):71S-76S. PubMed ID: 6753907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin-converting enzyme inhibitors: considerations regarding proteinuria.
    Lewis EJ
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):30-8. PubMed ID: 3037887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of a 5-year study with captopril in patients with severe therapy-resistant hypertension].
    Schrader J; Schoel G; Scheler F
    Klin Wochenschr; 1986 Aug; 64(15):695-700. PubMed ID: 3020311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of converting enzyme and angiotensin II inhibitors in chronic one kidney bipolar ligated hypertension.
    Loyke HF
    Pharmacol Res Commun; 1981 May; 13(5):501-9. PubMed ID: 6270704
    [No Abstract]   [Full Text] [Related]  

  • 31. [Progressive reversible kidney insufficiency after blood pressure reduction with captopril].
    Kindler J; Konrads A; Meurer KA; Sieberth HG
    Internist (Berl); 1981 Jun; 22(6):360-3. PubMed ID: 6265394
    [No Abstract]   [Full Text] [Related]  

  • 32. [A case of bilateral renovascular hypertension controlled by angiotensin converting enzyme inhibitor (captopril) after arterioplasty for predominantly stenotic side (author's transl)].
    Sakoda H; Ohashi H; Yoshida H; Morimoto K; Kawai C; Hara A; Matsunaga M; Kawamura J; Kumada K
    Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):167-73. PubMed ID: 7047823
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term captopril treatment in moderate to severe hypertension.
    Santucci A; Aguglia F; De Mattia G; Ficara C; Balsano F
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):77S-79S. PubMed ID: 6753908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of captopril on severe renin-dependent hypertension of uraemics on regular dialysis treatment.
    Pyrpasopoulos M; Sion M; Paraskevopoulos G; Zuruzoglu W; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1983; 5(2):131-4. PubMed ID: 6348445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute and chronic treatment of severe and malignant hypertension with the oral angiotensin-converting enzyme inhibitor captopril.
    Case DB; Atlas SA; Sullivan PA; Laragh JH
    Circulation; 1981 Oct; 64(4):765-71. PubMed ID: 6168412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of captopril on both hypertension and proteinuria. Report of a case of renovascular hypertension associated with nephrotic syndrome.
    Takeda R; Morimoto S; Uchida K; Kigoshi T; Sumitani T; Matsubara F
    Arch Intern Med; 1980 Nov; 140(11):1531-3. PubMed ID: 7002084
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET; Stinson J; Ramirez G
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute and chronic systemic and pulmonary hemodynamic effects of angiotensin converting enzyme inhibition with captopril in hypertensive patients.
    Fagard R; Amery A; Reybrouck T; Lijnen P; Billiet L
    Am J Cardiol; 1980 Aug; 46(2):295-300. PubMed ID: 6250392
    [No Abstract]   [Full Text] [Related]  

  • 40. [Captopril in the clinical treatment of renovascular hypertension].
    Ribeiro AB; Alves Filho G; de Almeida FA; Kohlmann Junior O; Stella SR; Ramos OL
    AMB Rev Assoc Med Bras; 1980 May; 26(5):153-6. PubMed ID: 7005991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.